Comprehensive Characterization of Reference Standard Lots of HIV-1 Subtype C Gp120 Proteins for Clinical Trials in Southern African Regions

Two HIV-1 subtype C gp120 protein candidates were the selected antigens for several experimental vaccine regimens now under evaluation in HVTN 100 Phase I/II clinical trial aiming to support the start of the HVTN 702 Phase IIb/III trial in southern Africa, which is designed to confirm and extend the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zihao, Lorin, Clarisse, Koutsoukos, Marguerite, Franco, David, Bayat, Babak, Zhang, Ying, Carfi, Andrea, Barnett, Susan W., Porter, Frederick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931634/
https://www.ncbi.nlm.nih.gov/pubmed/27187483
http://dx.doi.org/10.3390/vaccines4020017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931634/
https://www.ncbi.nlm.nih.gov/pubmed/27187483
http://dx.doi.org/10.3390/vaccines4020017

Ejemplares similares